1. Medtech Insight
  2. >>Archive

Stroke Devices: Hope Amid Headwinds

Despite market headwinds, the endovascular treatment of acute ischemic stroke remains a growing and highly under-penetrated market opportunity valued at more than $1 billion worldwide. Although advances in neurothrombectomy devices, access catheters, imaging, and neuroprotective therapies have the potential to help expand the treatable population, positive Level I clinical evidence is needed to drive adoption and market growth.

Despite market headwinds, endovascular treatments for acute ischemic stroke (AIS) continue to represent a large, rapidly emerging market with a worldwide opportunity estimated at more than $1 billion. Several factors have been slowing growth in this market of late, including recent clinical trial results, looming threats to reimbursement, increasing regulatory requirements, and a challenging funding environment. However, the long-term outlook remains positive. The fundamentals are sound and will continue to drive growth in this space for many years to come.

The demand is clearly there. According to the American Heart Association (AHA)/American Stroke Association (ASA), almost 800,000 people in the...

More from Archive

More from Medtech Insight

With LDT Rule DOA, Could FDA Shift Focus To RUOs?

 
• By Brian Bossetta

Now that the US FDA has chosen not to appeal a March ruling effectively killing the agency’s efforts to regulate lab-developed tests as medical devices, will the agency adopt a different strategy to flex its regulatory muscle?

Execs On The Move: 2-6 June 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Ellipsis Raises $45M To Expand AI Care Manager Across Health Systems

 
• By Marion Webb

Ellipsis said it will use its new funding to expand its AI-powered voice assistant Sage across health systems. Ellipsis is part of the global vocal biomarker market, which is expected to exceed $9bn by the end of 2033, according to a research market report.